Emerging evidence highlights that integrating baseline clinicopathological characteristics with longitudinal imaging features enhances the characterization of tumor temporal heterogeneity and NAT responsiveness, thereby improving outcome prediction accuracy 28. The gene discussed is BRD2; the disease is neoplasm.